Skip to main content
. 2023 Sep 8;23:844. doi: 10.1186/s12885-023-11192-8

Fig. 6.

Fig. 6

Quantitative analysis of the targeted L-ARG/NO pathway analytes: arginine, SDMA and ADMA. A Blood analyte abundance in normal, stage I, III, and IV samples. B SDMA/ARG ratio as a biomarker to classify different stage cancers from the normal controls